On September 1, 2021 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in September (Press release, ORIC Pharmaceuticals, SEP 1, 2021, View Source [SID1234587109]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference – Panel discussion titled "Aiming for the Bull’s Eye – Latest Advances in Targeted Oncology" on Friday, September 10, 2021, at 9:45 a.m. ET

H.C. Wainwright 23rd Annual Global Investment Conference – Presenting company overview on Monday, September 13, 2021, at 7:00 am ET

Baird 2021 Virtual Global Healthcare Conference – Presenting company overview on Wednesday, September 15, 2021, at 2:00 p.m. ET

Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit – Participating in a virtual fireside chat on Wednesday, September 22, 2021, at 2:55 p.m. ET

2021 Cantor Virtual Global Healthcare Conference – Participating in a virtual fireside chat on Thursday, September 30, 2021, at 10:00 a.m. ET
Webcasts of the Citi, H.C. Wainwright, Oppenheimer, and Cantor presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of webcasts will be available for 90 days following the events.